Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Magnetite Zinc Oxide Composite Nanoparticles for Oral Potentially Malignant Lesions
NCT06271564Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Feb 2024
- Primary completion
- Dec 2025
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of magnetite + zinc oxide in Oral potentially malignant disorders (OPMD), sponsored by Ain Shams University. Started Feb 2024; status: completed.
02
Drugs
magnetite + zinc oxide
03
Conditions
Oral potentially malignant disorders (OPMD)
Beyond the preview
Go deeper on NCT06271564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06271564.